Lv4
480 积分 2022-11-25 加入
Targeting the Menin– KMT2A Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader Inhibitors
2天前
已完结
A Comprehensive Review of Traditional Chinese Medicine Ejiao (Colla Corii Asini): Chemical Composition, Quality Control, and Pharmacological Actions
22天前
已完结
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
23天前
已完结
Recombinant CHO Cell Pool Generation Using piggyBac Transposon System
1个月前
已完结
KAT6 inhibitors under investigation for solid tumors: the preclinical and early phase progress
1个月前
已完结
Discovery of a Novel Napabucasin Derivative B16 as a Potent STAT3 Inhibitor for the Treatment of Triple-Negative Breast Cancer
2个月前
已完结
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
5个月前
已完结
IL-18 drives the Bhlhe40-mediated pathogenic Th17 cell response and exacerbates autoimmune disease progression
5个月前
已完结
Targeting DHX9 helicase with the novel small-molecule inhibitor ATX968 induces replication stress and innate immunity in small cell lung cancer
5个月前
已关闭
Targeting CDK2 and other novel cell cycle targets for breast cancer therapy
6个月前
已完结
皖公网安备34019202002308
